查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1620657

藥物分析測試外包市場：按服務、測試方法和最終用途分類 - 2025-2030 年全球預測

Pharmaceutical Analytical Testing Outsourcing Market by Services (Bioanalytical Testing, Method Development & Validation, Stability Testing), Testing Technique (Chromatography, Mass Spectrometry, Spectroscopy), End-use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

根據預測，2023年藥物分析測試外包市值為92.3億美元，預計2024年將達到100.7億美元，複合年成長率為9.38%，到2030年將達到173億美元。

藥品分析檢測外包是指委託藥品的實驗室檢測和分析評估工作外包給外部機構。需求包括專業知識、成本效率、法規遵循以及對核心能力的關注。應用包括穩定性測試、方法驗證、原料分析和微生物測試，最終用途包括製藥、生技公司和醫療設備。主要成長動力包括藥物開發日益複雜、監管更加嚴格以及藥物開發成本進一步降低。在分析測試中擴大採用人工智慧和機器學習等先進技術帶來了潛在的機會。鼓勵公司利用這些技術來提高準確性和效率，並探索策略夥伴關係以擴大服務能力和地理覆蓋範圍。然而，成長受到潛在資料安全挑戰、依賴可能影響時間表的外部機構的風險以及全球公司之間不同的品質標準等因素的阻礙。嚴格遵守不斷發展的國際監管標準的需要也是阻礙因素。市場發展可以透過開發個人化測試解決方案、整合巨量資料分析進行預測品質評估以及利用自動化系統來確保速度和準確性來推動。此外，與學術機構和科技新興企業的合作可能會帶來新的測試方法和可擴展的解決方案。市場的本質是動態和競爭的，既有成熟的服務供應商，也有新興的參與者提供客製化的解決方案。隨著競爭格局的演變，企業必須保持敏捷並適應不斷變化的行業需求，確保強大的品管框架，並繼續投資於技術進步和培訓以保持競爭優勢。為了領先於合規性變化，公司必須主動與監管機構合作，並將新實踐無縫整合到業務工作流程中。

主要市場統計
基準年[2023] 92.3億美元
預測年份 [2024] 100.7億美元
預測年份 [2030] 173億美元
複合年成長率（%） 9.38%

市場動態：快速發展的藥物分析測試外包市場的關鍵市場洞察

藥品分析測試外包市場正因供需的動態交互作用而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 增加藥物發現與開發的研發
    • 藥物配方的複雜性日益增加以及符合嚴格監管標準的需要
    • 人們越來越偏好將藥物分析測試外包作為成本最佳化策略
  • 市場限制因素
    • 維護分析設備和最先進設備的成本高昂
  • 市場機會
    • 藥物檢測程序的新技術進展
    • 加大醫藥產業投資力度
  • 市場挑戰
    • 智慧財產權問題

波特五力戰略工具引領藥物分析測試外包市場

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解藥物分析測試外包市場的外部影響

外部宏觀環境因素在塑造藥物分析測試外包市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解藥物分析測試外包市場的競爭狀況

藥物分析測試外包市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 藥物分析測試外包市場定位矩陣供應商績效評估

FPNV 定位矩陣是評估藥物分析測試外包市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議繪製藥物分析測試外包市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，對藥物分析測試外包市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告提供了涵蓋關鍵重點領域的市場全面分析：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開發：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、未開發地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 增加藥物發現和開發的研究和開發
      • 藥物處方的複雜性以及需要遵守嚴格的監管標準
      • 藥物分析測試外包作為一種成本最佳化策略越來越受歡迎
    • 抑制因素
      • 分析設備和最先進設備的維護高成本
    • 機會
      • 藥物檢測程序的新技術進展
      • 加大醫藥產業投資力度
    • 任務
      • 智慧財產權問題
  • 市場區隔分析
    • 服務：對生物分析測試服務的需求，以確定藥物的功效和安全性
    • 測試技術：層析法的主要優點在於其能夠有效率地分離和定量樣品中的分析物
    • 最終用途：契約製造組織對各種高度複雜的測試服務的需求不斷增加
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 藥物分析測試外包市場：依服務分類

  • 生物分析測試
    • 臨床
    • 非臨床
  • 方法開發和檢驗
    • 可萃取和可浸出
    • 雜質法
    • 技術諮詢
  • 穩定性測試
    • 加速穩定性測試
    • 藥物成分
    • 光穩定性測試
    • 穩定性指標檢驗

第7章依測試方法分類的藥物分析測試外包市場

  • 層析法
  • 質譜分析
  • 光譜學

第8章藥物分析測試外包市場：依最終用途

  • 生物製藥和藥品
  • 契約製造組織

第9章 北美、南美藥品分析測試外包市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太藥品分析測試外包市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東、非洲藥品分析測試外包市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Sterling Acuris 透過新收購擴展到製藥和分析測試領域
    • Eurofins 透過與日本Astellas Pharma 簽訂外包協議擴大生物製藥產品測試基地
  • 戰略分析和建議

公司名單

  • Ajinomoto Bio-Pharma
  • Alcami Corporation
  • AptarGroup, Inc.
  • Ascendia Pharmaceuticals
  • BioAgilytix
  • Cambrex Corporation
  • Catalent, Inc
  • Charles River Laboratories International, Inc.
  • Element Materials Technology
  • Eurofins Scientific SE
  • ICON PLC
  • Intertek Group PLC
  • Laboratory Corporation of America Holdings
  • LGM Pharma
  • Medpace Holdings, Inc.
  • Merck KGaA
  • Pace Analytical Services, Inc.
  • SGS SA
  • Societal CDMO
  • Source BioScience
  • Syneos Health
  • Thermo Fisher Scientific Inc.
  • West Pharmaceutical Services, Inc.
  • WuXi AppTec
Product Code: MRR-A339DAEFAEE4

The Pharmaceutical Analytical Testing Outsourcing Market was valued at USD 9.23 billion in 2023, expected to reach USD 10.07 billion in 2024, and is projected to grow at a CAGR of 9.38%, to USD 17.30 billion by 2030.

Pharmaceutical Analytical Testing Outsourcing refers to contracting external organizations to conduct laboratory testing and analytical assessments of pharmaceutical products. It is necessitated by a need for specialized expertise, cost efficiency, regulatory compliance, and the ability to focus on core competencies. Applications include stability testing, method validation, raw material analysis, and microbiological testing, while end-use avenues cover pharmaceuticals, biotechnology firms, and medical devices. Key growth drivers include the rising complexity of drug development, stringent regulatory mandates, and the push for cost reduction in pharmaceutical development. The increasing adoption of advanced technologies like AI and machine learning for analytical testing presents potential opportunities; companies are recommended to leverage these technologies to improve accuracy and efficiency and explore strategic partnerships to expand service capabilities and geographical reach. However, growth is challenged by factors such as potential breaches in data security, dependency risks on external agencies that could affect timelines, and variability in quality standards across global players. The need for rigorous compliance with evolving international regulatory standards also poses a limitation. Market innovation can be driven by developing personalised testing solutions, integrating big data analytics for predictive quality assessments, and leveraging automated systems to ensure speed and precision. Moreover, collaboration with academic institutions and tech startups might yield new testing methodologies and scalable solutions. The nature of the market is dynamic and competitive, with a mix of established service providers and emerging players offering tailored solutions. As the landscape evolves, businesses must remain agile and responsive to changing industry needs, ensuring robust quality control frameworks while continuously investing in technological advancements and training to maintain a competitive advantage. Companies should proactively engage with regulatory bodies to stay ahead of compliance changes, ensuring seamless integration of new practices into their operational workflows.

KEY MARKET STATISTICS
Base Year [2023] USD 9.23 billion
Estimated Year [2024] USD 10.07 billion
Forecast Year [2030] USD 17.30 billion
CAGR (%) 9.38%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Pharmaceutical Analytical Testing Outsourcing Market

The Pharmaceutical Analytical Testing Outsourcing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing research and development in drug discovery and development
    • Complexity of drug formulations and need for compliance with stringent regulatory standards
    • Growing preferences for pharmaceutical analytical testing outsourcing as a cost optimization strategy
  • Market Restraints
    • High cost of analytical instruments and maintaining state-of-the-art facilities
  • Market Opportunities
    • Emerging technological advancements in drug testing procedures
    • Increasing investments in the pharmaceutical industry
  • Market Challenges
    • Concerns associated with intellectual property rights

Porter's Five Forces: A Strategic Tool for Navigating the Pharmaceutical Analytical Testing Outsourcing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Pharmaceutical Analytical Testing Outsourcing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Pharmaceutical Analytical Testing Outsourcing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Pharmaceutical Analytical Testing Outsourcing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Pharmaceutical Analytical Testing Outsourcing Market

A detailed market share analysis in the Pharmaceutical Analytical Testing Outsourcing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Pharmaceutical Analytical Testing Outsourcing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Pharmaceutical Analytical Testing Outsourcing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Pharmaceutical Analytical Testing Outsourcing Market

A strategic analysis of the Pharmaceutical Analytical Testing Outsourcing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Pharmaceutical Analytical Testing Outsourcing Market, highlighting leading vendors and their innovative profiles. These include Ajinomoto Bio-Pharma, Alcami Corporation, AptarGroup, Inc., Ascendia Pharmaceuticals, BioAgilytix, Cambrex Corporation, Catalent, Inc, Charles River Laboratories International, Inc., Element Materials Technology, Eurofins Scientific SE, ICON PLC, Intertek Group PLC, Laboratory Corporation of America Holdings, LGM Pharma, Medpace Holdings, Inc., Merck KGaA, Pace Analytical Services, Inc., SGS SA, Societal CDMO, Source BioScience, Syneos Health, Thermo Fisher Scientific Inc., West Pharmaceutical Services, Inc., and WuXi AppTec.

Market Segmentation & Coverage

This research report categorizes the Pharmaceutical Analytical Testing Outsourcing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Services, market is studied across Bioanalytical Testing, Method Development & Validation, and Stability Testing. The Bioanalytical Testing is further studied across Clinical and Non-Clinical. The Method Development & Validation is further studied across Extractable & Leachable, Impurity Method, and Technical Consulting. The Stability Testing is further studied across Accelerated Stability Testing, Drug Substance, Photostability Testing, and Stability Indicating Method Validation.
  • Based on Testing Technique, market is studied across Chromatography, Mass Spectrometry, and Spectroscopy.
  • Based on End-use, market is studied across Biopharmaceuticals & Pharmaceuticals and Contract Manufacturing Organizations.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing research and development in drug discovery and development
      • 5.1.1.2. Complexity of drug formulations and need for compliance with stringent regulatory standards
      • 5.1.1.3. Growing preferences for pharmaceutical analytical testing outsourcing as a cost optimization strategy
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of analytical instruments and maintaining state-of-the-art facilities
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging technological advancements in drug testing procedures
      • 5.1.3.2. Increasing investments in the pharmaceutical industry
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns associated with intellectual property rights
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Services: Demand for bioanalytical testing services to determine efficacy and safety of pharmaceutical products
    • 5.2.2. Testing Technique: Significant benefits of chromatography owing to its efficiency in separating and quantifying analytes in samples
    • 5.2.3. End-use: Growing need for a broad range of high-complexity testing services from contract manufacturing organizations
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Pharmaceutical Analytical Testing Outsourcing Market, by Services

  • 6.1. Introduction
  • 6.2. Bioanalytical Testing
    • 6.2.1. Clinical
    • 6.2.2. Non-Clinical
  • 6.3. Method Development & Validation
    • 6.3.1. Extractable & Leachable
    • 6.3.2. Impurity Method
    • 6.3.3. Technical Consulting
  • 6.4. Stability Testing
    • 6.4.1. Accelerated Stability Testing
    • 6.4.2. Drug Substance
    • 6.4.3. Photostability Testing
    • 6.4.4. Stability Indicating Method Validation

7. Pharmaceutical Analytical Testing Outsourcing Market, by Testing Technique

  • 7.1. Introduction
  • 7.2. Chromatography
  • 7.3. Mass Spectrometry
  • 7.4. Spectroscopy

8. Pharmaceutical Analytical Testing Outsourcing Market, by End-use

  • 8.1. Introduction
  • 8.2. Biopharmaceuticals & Pharmaceuticals
  • 8.3. Contract Manufacturing Organizations

9. Americas Pharmaceutical Analytical Testing Outsourcing Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Pharmaceutical Analytical Testing Outsourcing Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Pharmaceutical Analytical Testing Outsourcing Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Sterling Accuris expands into pharmaceutical and analytical testing through new acquisition
    • 12.3.2. Eurofins expands its biopharmaceutical products testing footprint with an outsourcing agreement with Astellas in Japan
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Ajinomoto Bio-Pharma
  • 2. Alcami Corporation
  • 3. AptarGroup, Inc.
  • 4. Ascendia Pharmaceuticals
  • 5. BioAgilytix
  • 6. Cambrex Corporation
  • 7. Catalent, Inc
  • 8. Charles River Laboratories International, Inc.
  • 9. Element Materials Technology
  • 10. Eurofins Scientific SE
  • 11. ICON PLC
  • 12. Intertek Group PLC
  • 13. Laboratory Corporation of America Holdings
  • 14. LGM Pharma
  • 15. Medpace Holdings, Inc.
  • 16. Merck KGaA
  • 17. Pace Analytical Services, Inc.
  • 18. SGS SA
  • 19. Societal CDMO
  • 20. Source BioScience
  • 21. Syneos Health
  • 22. Thermo Fisher Scientific Inc.
  • 23. West Pharmaceutical Services, Inc.
  • 24. WuXi AppTec

LIST OF FIGURES

  • FIGURE 1. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET RESEARCH PROCESS
  • FIGURE 2. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET DYNAMICS
  • TABLE 7. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CLINICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY NON-CLINICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY EXTRACTABLE & LEACHABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY IMPURITY METHOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNICAL CONSULTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY ACCELERATED STABILITY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DRUG SUBSTANCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PHOTOSTABILITY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY INDICATING METHOD VALIDATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SPECTROSCOPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOPHARMACEUTICALS & PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 80. AUSTRALIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 81. CHINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 82. CHINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 84. CHINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 85. CHINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 86. CHINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 87. INDIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 88. INDIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 89. INDIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 90. INDIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 91. INDIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 92. INDIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 93. INDONESIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 94. INDONESIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 95. INDONESIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 96. INDONESIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 97. INDONESIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 98. INDONESIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 99. JAPAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 100. JAPAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 101. JAPAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 102. JAPAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 103. JAPAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 104. JAPAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 105. MALAYSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 106. MALAYSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 107. MALAYSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 108. MALAYSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 109. MALAYSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 110. MALAYSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 111. PHILIPPINES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 112. PHILIPPINES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 114. PHILIPPINES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 116. PHILIPPINES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 117. SINGAPORE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 118. SINGAPORE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 119. SINGAPORE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 120. SINGAPORE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 121. SINGAPORE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 122. SINGAPORE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH KOREA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH KOREA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH KOREA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH KOREA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 129. TAIWAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 130. TAIWAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 131. TAIWAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 132. TAIWAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 133. TAIWAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 134. TAIWAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 135. THAILAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 136. THAILAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 137. THAILAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 138. THAILAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 139. THAILAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 140. THAILAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 141. VIETNAM PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 142. VIETNAM PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 143. VIETNAM PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 144. VIETNAM PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 145. VIETNAM PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 146. VIETNAM PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 154. DENMARK PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 155. DENMARK PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 156. DENMARK PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 157. DENMARK PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 158. DENMARK PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 159. DENMARK PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 160. EGYPT PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 161. EGYPT PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 162. EGYPT PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 163. EGYPT PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 164. EGYPT PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 165. EGYPT PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 166. FINLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 167. FINLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 168. FINLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 169. FINLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 170. FINLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 171. FINLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 172. FRANCE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 173. FRANCE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 174. FRANCE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 175. FRANCE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 176. FRANCE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 177. FRANCE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 178. GERMANY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 179. GERMANY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 180. GERMANY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 181. GERMANY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 182. GERMANY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 183. GERMANY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 184. ISRAEL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 185. ISRAEL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 186. ISRAEL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 187. ISRAEL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 188. ISRAEL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 189. ISRAEL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 190. ITALY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 191. ITALY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 192. ITALY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 193. ITALY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 194. ITALY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 195. ITALY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 196. NETHERLANDS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 197. NETHERLANDS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 198. NETHERLANDS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 200. NETHERLANDS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 202. NIGERIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 203. NIGERIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 204. NIGERIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 205. NIGERIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 206. NIGERIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 207. NIGERIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 208. NORWAY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 209. NORWAY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 210. NORWAY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 211. NORWAY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 212. NORWAY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 213. NORWAY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 214. POLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 215. POLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 216. POLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 217. POLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 218. POLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 219. POLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 220. QATAR PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 221. QATAR PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 222. QATAR PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 223. QATAR PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 224. QATAR PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 225. QATAR PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 226. RUSSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 227. RUSSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 228. RUSSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 229. RUSSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 230. RUSSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 231. RUSSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 232. SAUDI ARABIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 233. SAUDI ARABIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 234. SAUDI ARABIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 236. SAUDI ARABIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 238. SOUTH AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 239. SOUTH AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 244. SPAIN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 245. SPAIN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 246. SPAIN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 247. SPAIN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 248. SPAIN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 249. SPAIN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 250. SWEDEN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 251. SWEDEN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 252. SWEDEN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 253. SWEDEN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 254. SWEDEN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 255. SWEDEN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 256. SWITZERLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 257. SWITZERLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 258. SWITZERLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
  • TABLE 260. SWITZERLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 262. TURKEY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 263. TURKEY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)

TABLE